|
ZNF674 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.93270000000379E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.07159999999762E-05 |
| Normal-vs-Stage2 |
3.583800E-01 |
| Normal-vs-Stage3 |
4.457000E-03 |
| Normal-vs-Stage4 |
4.236500E-03 |
| Stage1-vs-Stage2 |
4.500200E-01 |
| Stage1-vs-Stage3 |
7.640000E-01 |
| Stage1-vs-Stage4 |
7.872600E-01 |
| Stage2-vs-Stage3 |
5.755600E-01 |
| Stage2-vs-Stage4 |
4.076400E-01 |
| Stage3-vs-Stage4 |
6.388800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.805830E-04 |
| Normal-vs-AfricanAmerican |
2.884400E-03 |
| Normal-vs-Asian |
5.156700E-03 |
| Caucasian-vs-AfricanAmerican |
8.352000E-01 |
| Caucasian-vs-Asian |
5.817800E-01 |
| AfricanAmerican-vs-Asian |
6.493400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.61389999997485E-06 |
| Normal-vs-Female |
3.745800E-01 |
| Male-vs-Female |
3.482000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.969200E-04 |
| Normal-vs-Extreme_Weight |
2.421700E-04 |
| Normal-vs-Obese |
2.418200E-02 |
| Normal-vs-Extreme_Obese |
1.795800E-04 |
| Normal_Weight-vs-Extreme_Weight |
9.606800E-01 |
| Normal_Weight-vs-Obese |
2.014200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.356800E-01 |
| Extreme_Weight-vs-Obese |
2.378600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.439600E-01 |
| Obese-vs-Extreme_Obese |
6.291700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.799700E-02 |
| Normal-vs-Age(41-60Yrs) |
7.041100E-03 |
| Normal-vs-Age(61-80Yrs) |
3.90249999999703E-05 |
| Normal-vs-Age(81-100Yrs) |
4.41090000000699E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.470600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.543230E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.882500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.148300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.452100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.239000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.00619999999919E-05 |
| Normal-VS-Type2 PRCC |
4.51629999997927E-06 |
| Normal-VS-KIRP CIMP |
1.982800E-01 |
| Normal-VS-Unclassified PRCC |
2.007800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.415570E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.186000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.405600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.754440E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.825700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.752600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11950000003525E-06 |
| Normal-vs-N1 |
9.180300E-02 |
| Normal-vs-N2 |
7.154000E-02 |
| N0-vs-N1 |
4.714100E-02 |
| N0-vs-N2 |
7.128800E-01 |
| N1-vs-N2 |
6.200000E-01 |
|
|
